These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 20120404

  • 1. Metabolic and physico-chemical urolithiasis parameters in the first morning urine.
    Serić V, Dutour-Sikirić M, Mihaljević I, Tucak-Zorić S, Bilić-Curcić I, Babić-Ivancić V.
    Coll Antropol; 2009 Dec; 33 Suppl 2():85-92. PubMed ID: 20120404
    [Abstract] [Full Text] [Related]

  • 2. Metabolic evaluation of urolithiasis patients from eastern Croatia.
    Babić-Ivancić V, Avdagić SC, Serić V, Kontrec J, Tucak A, Füredi-Milhofer H, Marković M.
    Coll Antropol; 2004 Dec; 28(2):655-66. PubMed ID: 15666597
    [Abstract] [Full Text] [Related]

  • 3. [Sodium excretion in children with lithogenic disorders].
    Kovacević L, Kovacević S, Smoljanić Z, Peco-Antić A, Kostić N, Gajić M, Kovacević N, Jovanović O.
    Srp Arh Celok Lek; 1998 Dec; 126(9-10):321-6. PubMed ID: 9863402
    [Abstract] [Full Text] [Related]

  • 4. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W, Kochakarn W, Ruangraksa C, Domrongkitchaiporn S.
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [Abstract] [Full Text] [Related]

  • 5. Twenty-four hour and spot urine metabolic evaluations: correlations versus agreements.
    Hong YH, Dublin N, Razack AH, Mohd MA, Husain R.
    Urology; 2010 Jun; 75(6):1294-8. PubMed ID: 19914693
    [Abstract] [Full Text] [Related]

  • 6. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL.
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [Abstract] [Full Text] [Related]

  • 7. [Urinary citrate excretion in children with calcium urolithiasis].
    Sikora P, Bieniaś B, Majewski M, Borzecka H, Wawrzyszuk M, Zajaczkowska M.
    Przegl Lek; 2006 Mar; 63 Suppl 3():134-6. PubMed ID: 16898511
    [Abstract] [Full Text] [Related]

  • 8. Bonn Risk Index based micromethod for assessing risk of urinary calcium oxalate stone formation.
    Porowski T, Mrozek P, Sidun J, Zoch-Zwierz W, Konstantynowicz J, Kirejczyk JK, Motkowski R, Laube N.
    J Urol; 2010 Mar; 183(3):1157-62. PubMed ID: 20096860
    [Abstract] [Full Text] [Related]

  • 9. Calcium oxalate urolithiasis in children: urinary promoters/inhibitors and role of their ratios.
    Turudic D, Batinic D, Golubic AT, Lovric M, Milosevic D.
    Eur J Pediatr; 2016 Dec; 175(12):1959-1965. PubMed ID: 27730307
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic action of citrate in urolithiasis explained by chemical speciation: increase in pH is the determinant factor.
    Rodgers A, Allie-Hamdulay S, Jackson G.
    Nephrol Dial Transplant; 2006 Feb; 21(2):361-9. PubMed ID: 16249202
    [Abstract] [Full Text] [Related]

  • 11. Clinical and metabolic evaluation of Korean patients with urolithiasis.
    Park KJ, Jeon SS, Han DH, Lee SY.
    Scand J Clin Lab Invest; 2011 Oct; 71(6):481-5. PubMed ID: 21714706
    [Abstract] [Full Text] [Related]

  • 12. [Risk of lithiasis and urolithiasis in children with unspecific inflammatory bowel disease].
    Makosiej R, Czkwianianc E, Niedworok M, Małecka-Panas E.
    Pol Merkur Lekarski; 2007 May; 22(131):410-3. PubMed ID: 17679383
    [Abstract] [Full Text] [Related]

  • 13. Idiopathic recurrent calcium urolithiasis (IRCU): an acid meal challenge uncovers inappropriate pH of postprandial, fasting and daily urine: a cross-sectional study of male patients providing insight into post- and pre-load urinary stone substances, crystallization risk, presence of stones, renal transport and systemic metabolic factors.
    Schwille PO, Wipplinger J.
    Eur J Med Res; 2008 Jul 28; 13(7):332-42. PubMed ID: 18700191
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of factors involved in calcium stone formation.
    Abraham PA, Smith CL.
    Miner Electrolyte Metab; 1987 Jul 28; 13(3):201-8. PubMed ID: 3627051
    [Abstract] [Full Text] [Related]

  • 15. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A, Meola M, D'Alessandro C, Bernabini G, Pasquali E, Carpi A, Barsotti G.
    Biomed Pharmacother; 2007 Jan 28; 61(1):86-90. PubMed ID: 17184967
    [Abstract] [Full Text] [Related]

  • 16. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T, Taguchi H.
    Hinyokika Kiyo; 1988 Sep 28; 34(9):1543-7. PubMed ID: 3213790
    [Abstract] [Full Text] [Related]

  • 17. Twenty four hours urine and serum biochemical parameters in patients with urolithiasis.
    Jawalekar S, Surve VT, Bhutey AK.
    Nepal Med Coll J; 2010 Mar 28; 12(1):5-7. PubMed ID: 20677601
    [Abstract] [Full Text] [Related]

  • 18. Comparison of biochemistry and diet in patients with enterocystoplasty who do and do not form stones.
    Hamid R, Robertson WG, Woodhouse CR.
    BJU Int; 2008 Jun 28; 101(11):1427-32. PubMed ID: 18284409
    [Abstract] [Full Text] [Related]

  • 19. Urinary metabolic evaluations in solitary and recurrent stone forming children.
    DeFoor W, Minevich E, Jackson E, Reddy P, Clark C, Sheldon C, Asplin J.
    J Urol; 2008 Jun 28; 179(6):2369-72. PubMed ID: 18433777
    [Abstract] [Full Text] [Related]

  • 20. Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test.
    Voss S, Hesse A, Zimmermann DJ, Sauerbruch T, von Unruh GE.
    J Urol; 2006 May 28; 175(5):1711-5. PubMed ID: 16600737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.